Glaukos Current Ratio 2014-2025 | GKOS
Current and historical current ratio for Glaukos (GKOS) from 2014 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Glaukos current ratio for the three months ending March 31, 2025 was 6.49.
| Glaukos Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-03-31 | $0.45B | $0.07B | 6.49 |
| 2024-12-31 | $0.45B | $0.08B | 5.99 |
| 2024-09-30 | $0.40B | $0.07B | 5.54 |
| 2024-06-30 | $0.38B | $0.07B | 5.48 |
| 2024-03-31 | $0.39B | $0.07B | 5.38 |
| 2023-12-31 | $0.40B | $0.07B | 5.34 |
| 2023-09-30 | $0.40B | $0.07B | 5.95 |
| 2023-06-30 | $0.40B | $0.06B | 6.28 |
| 2023-03-31 | $0.42B | $0.06B | 6.67 |
| 2022-12-31 | $0.44B | $0.07B | 6.13 |
| 2022-09-30 | $0.45B | $0.06B | 7.41 |
| 2022-06-30 | $0.47B | $0.07B | 6.78 |
| 2022-03-31 | $0.49B | $0.06B | 8.84 |
| 2021-12-31 | $0.49B | $0.06B | 7.67 |
| 2021-09-30 | $0.50B | $0.06B | 7.91 |
| 2021-06-30 | $0.49B | $0.35B | 1.40 |
| 2021-03-31 | $0.47B | $0.34B | 1.41 |
| 2020-12-31 | $0.47B | $0.05B | 9.45 |
| 2020-09-30 | $0.45B | $0.05B | 9.73 |
| 2020-06-30 | $0.45B | $0.06B | 8.27 |
| 2020-03-31 | $0.23B | $0.05B | 4.53 |
| 2019-12-31 | $0.26B | $0.06B | 4.56 |
| 2019-09-30 | $0.21B | $0.03B | 6.32 |
| 2019-06-30 | $0.20B | $0.03B | 6.49 |
| 2019-03-31 | $0.18B | $0.03B | 6.72 |
| 2018-12-31 | $0.18B | $0.03B | 5.82 |
| 2018-09-30 | $0.18B | $0.03B | 7.08 |
| 2018-06-30 | $0.16B | $0.02B | 7.63 |
| 2018-03-31 | $0.15B | $0.02B | 7.90 |
| 2017-12-31 | $0.15B | $0.03B | 5.58 |
| 2017-09-30 | $0.14B | $0.02B | 6.93 |
| 2017-06-30 | $0.13B | $0.02B | 6.86 |
| 2017-03-31 | $0.12B | $0.02B | 8.45 |
| 2016-12-31 | $0.12B | $0.02B | 7.09 |
| 2016-09-30 | $0.12B | $0.02B | 6.08 |
| 2016-06-30 | $0.11B | $0.02B | 6.01 |
| 2016-03-31 | $0.11B | $0.02B | 5.82 |
| 2015-12-31 | $0.10B | $0.02B | 5.11 |
| 2015-09-30 | $0.11B | $0.02B | 5.33 |
| 2015-06-30 | $0.11B | $0.02B | 5.33 |
| 2015-03-31 | $0.01B | $0.02B | 0.73 |
| 2014-12-31 | $0.01B | $0.02B | 0.52 |
| 2014-09-30 | $0.00B | 0.00 | |
| 2014-06-30 | $0.00B | 0.00 | |
| 2014-03-31 | $0.00B | 0.00 | |
| 2013-12-31 | $0.01B | $0.01B | 2.19 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $5.848B | $0.383B |
| Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $182.611B | 79.98 |
| Thermo Fisher Scientific (TMO) | United States | $148.189B | 17.92 |
| Edwards Lifesciences (EW) | United States | $43.397B | 28.45 |
| Alcon (ALC) | Switzerland | $41.812B | 28.26 |
| IDEXX Laboratories (IDXX) | United States | $41.807B | 48.04 |
| DexCom (DXCM) | United States | $31.765B | 49.10 |
| IQVIA Holdings (IQV) | United States | $26.748B | 14.98 |
| Mettler-Toledo (MTD) | United States | $23.806B | 28.31 |
| STERIS (STE) | Ireland | $23.238B | 25.59 |
| Waters (WAT) | United States | $20.195B | 28.49 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.992B | 0.00 |
| Hologic (HOLX) | United States | $14.255B | 15.49 |
| Sysmex ADR (SSMXY) | Japan | $10.670B | 30.27 |
| Penumbra (PEN) | United States | $9.953B | 78.12 |
| Masimo (MASI) | United States | $8.825B | 32.55 |
| Globus Medical (GMED) | United States | $7.767B | 18.51 |
| Teleflex (TFX) | United States | $5.202B | 8.59 |
| TransMedics (TMDX) | United States | $4.194B | 91.18 |
| Integer Holdings (ITGR) | United States | $4.151B | 21.75 |
| PROCEPT BioRobotics (PRCT) | United States | $3.301B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.463B | 14.67 |
| Veracyte (VCYT) | United States | $2.100B | 29.47 |
| Nihon Kohden (NHNKY) | Japan | $1.988B | 22.80 |
| Elekta AB (EKTAY) | Sweden | $1.883B | 16.93 |
| Alphatec Holdings (ATEC) | United States | $1.592B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.359B | 0.00 |
| Artivion (AORT) | United States | $1.268B | 118.80 |
| OPKO Health (OPK) | United States | $1.023B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.012B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.926B | 4.92 |
| Beta Bionics (BBNX) | United States | $0.771B | 0.00 |
| IRadimed (IRMD) | United States | $0.743B | 37.71 |
| SiBone (SIBN) | United States | $0.711B | 0.00 |
| RxSight (RXST) | United States | $0.564B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.559B | 8.69 |
| Mesa Laboratories (MLAB) | United States | $0.507B | 11.89 |
| Delcath Systems (DCTH) | United States | $0.493B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.489B | 0.00 |
| AxoGen (AXGN) | United States | $0.423B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.415B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.406B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.393B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.356B | 9.48 |
| NeuroPace (NPCE) | United States | $0.348B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.343B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.315B | 0.00 |
| 908 Devices (MASS) | United States | $0.286B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.232B | 14.03 |
| Neuronetics (STIM) | United States | $0.222B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.221B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.205B | 0.00 |
| Inogen (INGN) | United States | $0.177B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.177B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| CVRx (CVRX) | United States | $0.152B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.146B | 0.00 |
| LENSAR (LNSR) | United States | $0.145B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.137B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.136B | 0.00 |
| Accuray (ARAY) | United States | $0.127B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.105B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.104B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.090B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 47.40 |
| InspireMD (NSPR) | United States | $0.074B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.072B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.064B | 0.00 |
| Hyperfine (HYPR) | United States | $0.054B | 0.00 |
| Spectral AI (MDAI) | United States | $0.053B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.042B | 0.00 | |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.030B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.009B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.39 |